
Yesterday, the Medicines and Health Regulatory Authority (
@MHRAgovuk) and Joint Committee for Vaccination and Immunisation (JCVI) held a press conference setting out their advice for Covid-19 vaccination.

Here’s what we learnt...

We now know that the Pfizer/BioNTech vaccine has been approved for use, and people could start receiving the vaccine as early as next week.

There’s enough data to say this vaccine is safe, including for people with blood cancer, and has 95% effectiveness in the general population, although we don’t know how effective it is in people with blood cancer yet.

The government have plans to monitor people with the vaccine when they receive it, which could help us understand more about effectiveness in people with blood cancer.

We have confirmation from the government that all people who are ‘clinically extremely vulnerable’, which includes 200,000 people with blood cancer, will be prioritised at the same times as those between the ages of 70 and 75.

People in the same household as those with blood cancer will not be prioritised for the vaccine. This is because we don’t currently have evidence which shows that the vaccine stops the virus transmitting from person-to-person although this may change as more evidence emerges

We know that the government are planning to vaccinate those aged 16 years and over.

We’re currently seeking clarity about where people with blood cancer will receive the vaccine and what measures will be put in place to ensure this is covid safe.
We also don’t yet know when approvals for other vaccines will take place but hope this will happen soon.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.